Arjo AB (publ) - Asset Resilience Ratio
Arjo AB (publ) (ARJO-B) has an Asset Resilience Ratio of 0.18% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ARJO-B current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2023)
This chart shows how Arjo AB (publ)'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Arjo AB (publ) assets under control.
Liquid Assets Composition Over Time
This chart breaks down Arjo AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore how much of Arjo AB (publ)'s assets are long-term investments to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0% |
| Short-term Investments | Skr28.00 Million | 0.18% |
| Total Liquid Assets | Skr28.00 Million | 0.18% |
Asset Resilience Insights
- Limited Liquidity: Arjo AB (publ) maintains only 0.18% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Arjo AB (publ) Industry Peers by Asset Resilience Ratio
Compare Arjo AB (publ)'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
China National Medicines Corp Ltd
SHG:600511 |
Medical Distribution | 0.04% |
|
China National Accord Medicines Corp Ltd
SHE:200028 |
Medical Distribution | -1.21% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607 |
Medical Distribution | 4.21% |
Annual Asset Resilience Ratio for Arjo AB (publ) (2013–2023)
The table below shows the annual Asset Resilience Ratio data for Arjo AB (publ).
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.47% | Skr76.00 Million ≈ $8.18 Million |
Skr16.00 Billion ≈ $1.72 Billion |
-3.73pp |
| 2022-12-31 | 4.20% | Skr679.00 Million ≈ $73.07 Million |
Skr16.17 Billion ≈ $1.74 Billion |
+1.00pp |
| 2021-12-31 | 3.20% | Skr468.00 Million ≈ $50.36 Million |
Skr14.61 Billion ≈ $1.57 Billion |
-3.41pp |
| 2020-12-31 | 6.62% | Skr917.00 Million ≈ $98.68 Million |
Skr13.86 Billion ≈ $1.49 Billion |
+2.35pp |
| 2019-12-31 | 4.27% | Skr616.00 Million ≈ $66.29 Million |
Skr14.42 Billion ≈ $1.55 Billion |
-3.16pp |
| 2018-12-31 | 7.43% | Skr976.00 Million ≈ $105.03 Million |
Skr13.14 Billion ≈ $1.41 Billion |
+1.64pp |
| 2017-12-31 | 5.79% | Skr707.00 Million ≈ $76.08 Million |
Skr12.21 Billion ≈ $1.31 Billion |
-4.83pp |
| 2016-12-31 | 10.62% | Skr1.56 Billion ≈ $168.10 Million |
Skr14.71 Billion ≈ $1.58 Billion |
+10.22pp |
| 2015-12-31 | 0.39% | Skr55.00 Million ≈ $5.92 Million |
Skr14.02 Billion ≈ $1.51 Billion |
+0.07pp |
| 2014-12-31 | 0.32% | Skr48.00 Million ≈ $5.17 Million |
Skr14.82 Billion ≈ $1.60 Billion |
-0.29pp |
| 2013-12-31 | 0.61% | Skr81.00 Million ≈ $8.72 Million |
Skr13.22 Billion ≈ $1.42 Billion |
-- |
About Arjo AB (publ)
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and the Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, hygiene, prevention of pressure injuries and blood clots, and leg ulcer treatment… Read more